node1 | node2 | node1 accession | node2 accession | node1 annotation | node2 annotation | score |
APAF1 | BAK1 | ENSP00000448165 | ENSP00000353878 | apoptotic peptidase activating factor 1 | BCL2-antagonist/killer 1; In the presence of an appropriate stimulus, accelerates programmed cell death by binding to, and antagonizing the anti- apoptotic action of BCL2 or its adenovirus homolog E1B 19k protein. Low micromolar levels of zinc ions inhibit the promotion of apoptosis | 0.997 |
APAF1 | BAX | ENSP00000448165 | ENSP00000293288 | apoptotic peptidase activating factor 1 | BCL2-associated X protein | 0.981 |
APAF1 | BCL2 | ENSP00000448165 | ENSP00000329623 | apoptotic peptidase activating factor 1 | B-cell CLL/lymphoma 2; Suppresses apoptosis in a variety of cell systems including factor-dependent lymphohematopoietic and neural cells. Regulates cell death by controlling the mitochondrial membrane permeability. Appears to function in a feedback loop system with caspases. Inhibits caspase activity either by preventing the release of cytochrome c from the mitochondria and/or by binding to the apoptosis-activating factor (APAF-1) | 0.999 |
APAF1 | BCL2L1 | ENSP00000448165 | ENSP00000302564 | apoptotic peptidase activating factor 1 | BCL2-like 1; Potent inhibitor of cell death. Inhibits activation of caspases (By similarity). Appears to regulate cell death by blocking the voltage-dependent anion channel (VDAC) by binding to it and preventing the release of the caspase activator, CYC1, from the mitochondrial membrane. Also acts as a regulator of G2 checkpoint and progression to cytokinesis during mitosis | 0.999 |
APAF1 | BCL2L10 | ENSP00000448165 | ENSP00000260442 | apoptotic peptidase activating factor 1 | BCL2-like 10 (apoptosis facilitator); Promotes cell survival. Suppresses apoptosis induced by BAX but not BAK | 0.725 |
APAF1 | BCL2L2 | ENSP00000448165 | ENSP00000250405 | apoptotic peptidase activating factor 1 | BCL2-like 2; Promotes cell survival. Blocks dexamethasone-induced apoptosis. Mediates survival of postmitotic Sertoli cells by suppressing death-promoting activity of BAX | 0.719 |
APAF1 | BECN1 | ENSP00000448165 | ENSP00000355231 | apoptotic peptidase activating factor 1 | beclin 1, autophagy related; Plays a central role in autophagy. Required for the abcission step in cytokinesis. May play a role in antiviral host defense. Protects against infection by a neurovirulent strain of Sindbis virus | 0.434 |
APAF1 | ENSG00000258643 | ENSP00000448165 | ENSP00000451320 | apoptotic peptidase activating factor 1 | BCL2L2-PABPN1 readthrough; Promotes cell survival. Blocks dexamethasone-induced apoptosis. Mediates survival of postmitotic Sertoli cells by suppressing death-promoting activity of BAX | 0.948 |
APAF1 | UBC | ENSP00000448165 | ENSP00000344818 | apoptotic peptidase activating factor 1 | ubiquitin C | 0.755 |
BAK1 | APAF1 | ENSP00000353878 | ENSP00000448165 | BCL2-antagonist/killer 1; In the presence of an appropriate stimulus, accelerates programmed cell death by binding to, and antagonizing the anti- apoptotic action of BCL2 or its adenovirus homolog E1B 19k protein. Low micromolar levels of zinc ions inhibit the promotion of apoptosis | apoptotic peptidase activating factor 1 | 0.997 |
BAK1 | BAX | ENSP00000353878 | ENSP00000293288 | BCL2-antagonist/killer 1; In the presence of an appropriate stimulus, accelerates programmed cell death by binding to, and antagonizing the anti- apoptotic action of BCL2 or its adenovirus homolog E1B 19k protein. Low micromolar levels of zinc ions inhibit the promotion of apoptosis | BCL2-associated X protein | 0.988 |
BAK1 | BCL2 | ENSP00000353878 | ENSP00000329623 | BCL2-antagonist/killer 1; In the presence of an appropriate stimulus, accelerates programmed cell death by binding to, and antagonizing the anti- apoptotic action of BCL2 or its adenovirus homolog E1B 19k protein. Low micromolar levels of zinc ions inhibit the promotion of apoptosis | B-cell CLL/lymphoma 2; Suppresses apoptosis in a variety of cell systems including factor-dependent lymphohematopoietic and neural cells. Regulates cell death by controlling the mitochondrial membrane permeability. Appears to function in a feedback loop system with caspases. Inhibits caspase activity either by preventing the release of cytochrome c from the mitochondria and/or by binding to the apoptosis-activating factor (APAF-1) | 0.999 |
BAK1 | BCL2L1 | ENSP00000353878 | ENSP00000302564 | BCL2-antagonist/killer 1; In the presence of an appropriate stimulus, accelerates programmed cell death by binding to, and antagonizing the anti- apoptotic action of BCL2 or its adenovirus homolog E1B 19k protein. Low micromolar levels of zinc ions inhibit the promotion of apoptosis | BCL2-like 1; Potent inhibitor of cell death. Inhibits activation of caspases (By similarity). Appears to regulate cell death by blocking the voltage-dependent anion channel (VDAC) by binding to it and preventing the release of the caspase activator, CYC1, from the mitochondrial membrane. Also acts as a regulator of G2 checkpoint and progression to cytokinesis during mitosis | 0.999 |
BAK1 | BCL2L10 | ENSP00000353878 | ENSP00000260442 | BCL2-antagonist/killer 1; In the presence of an appropriate stimulus, accelerates programmed cell death by binding to, and antagonizing the anti- apoptotic action of BCL2 or its adenovirus homolog E1B 19k protein. Low micromolar levels of zinc ions inhibit the promotion of apoptosis | BCL2-like 10 (apoptosis facilitator); Promotes cell survival. Suppresses apoptosis induced by BAX but not BAK | 0.793 |
BAK1 | BCL2L2 | ENSP00000353878 | ENSP00000250405 | BCL2-antagonist/killer 1; In the presence of an appropriate stimulus, accelerates programmed cell death by binding to, and antagonizing the anti- apoptotic action of BCL2 or its adenovirus homolog E1B 19k protein. Low micromolar levels of zinc ions inhibit the promotion of apoptosis | BCL2-like 2; Promotes cell survival. Blocks dexamethasone-induced apoptosis. Mediates survival of postmitotic Sertoli cells by suppressing death-promoting activity of BAX | 0.862 |
BAK1 | BECN1 | ENSP00000353878 | ENSP00000355231 | BCL2-antagonist/killer 1; In the presence of an appropriate stimulus, accelerates programmed cell death by binding to, and antagonizing the anti- apoptotic action of BCL2 or its adenovirus homolog E1B 19k protein. Low micromolar levels of zinc ions inhibit the promotion of apoptosis | beclin 1, autophagy related; Plays a central role in autophagy. Required for the abcission step in cytokinesis. May play a role in antiviral host defense. Protects against infection by a neurovirulent strain of Sindbis virus | 0.933 |
BAK1 | UBC | ENSP00000353878 | ENSP00000344818 | BCL2-antagonist/killer 1; In the presence of an appropriate stimulus, accelerates programmed cell death by binding to, and antagonizing the anti- apoptotic action of BCL2 or its adenovirus homolog E1B 19k protein. Low micromolar levels of zinc ions inhibit the promotion of apoptosis | ubiquitin C | 0.631 |
BAX | APAF1 | ENSP00000293288 | ENSP00000448165 | BCL2-associated X protein | apoptotic peptidase activating factor 1 | 0.981 |
BAX | BAK1 | ENSP00000293288 | ENSP00000353878 | BCL2-associated X protein | BCL2-antagonist/killer 1; In the presence of an appropriate stimulus, accelerates programmed cell death by binding to, and antagonizing the anti- apoptotic action of BCL2 or its adenovirus homolog E1B 19k protein. Low micromolar levels of zinc ions inhibit the promotion of apoptosis | 0.988 |
BAX | BCL2 | ENSP00000293288 | ENSP00000329623 | BCL2-associated X protein | B-cell CLL/lymphoma 2; Suppresses apoptosis in a variety of cell systems including factor-dependent lymphohematopoietic and neural cells. Regulates cell death by controlling the mitochondrial membrane permeability. Appears to function in a feedback loop system with caspases. Inhibits caspase activity either by preventing the release of cytochrome c from the mitochondria and/or by binding to the apoptosis-activating factor (APAF-1) | 0.999 |